Suzhou MedicalSystem Technology Co., Ltd. (603990.SS)
CNY 14.1
(3.22%)
CNY 14.1
(3.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -316.64 Million | 50.51 Million | 36.03 Million | 100.47 Million | 22.04 Million | 48.67 Million |
| Net Income | -265.24 Million | 35.48 Million | 43.5 Million | 41.96 Million | 47.11 Million | 55.06 Million |
| Depreciation & Amortization | 33.71 Million | 16.84 Million | 16.09 Million | 14.63 Million | 13.95 Million | 12.07 Million |
| Deferred income taxes | -3.82 Million | -6.29 Million | -3.07 Million | -2.7 Million | -1.46 Million | 489.07 Thousand |
| Stock-based compensation | 8.97 Million | - | - | - | - | -1.7 Million |
| Change in working capital | -178.32 Million | -23.32 Million | -45.5 Million | 13.74 Million | -68.1 Million | -32 Million |
| Other non-cash items | 53.55 Million | 21.5 Million | 21.94 Million | 30.14 Million | 29.07 Million | 13.54 Million |
| Investing Cash Flow | -862.53 Million | 205.31 Million | -467.24 Million | -23.63 Million | -37.9 Million | 30.7 Million |
| Investments in PPE | -599.83 Million | -24.57 Million | -40.98 Million | -8.87 Million | -12.89 Million | -16.62 Million |
| Acquisitions | -2.85 Million | 413.47 Thousand | -101.23 Million | 13.32 Thousand | -35.68 Million | - |
| Investment purchases | -1.87 Billion | -1.13 Billion | -1.03 Billion | -55 Million | -56.68 Million | -140 Million |
| Sales/Maturities of investments | 1.61 Billion | 1.36 Billion | 702.19 Million | 55.22 Million | 50.16 Million | 201.68 Million |
| Other Investing Activities | -259.83 Million | 0.73 | 7.85 Million | -14.99 Million | 17.19 Million | -14.35 Million |
| Financing Cash Flow | 710.15 Million | 307.41 Million | -154.24 Million | 680.55 Million | -4.31 Million | 8.61 Million |
| Debt repayment | -441.3 Million | -149.5 Million | -170.82 Million | -185.32 Million | -247.71 Million | -70 Million |
| Dividends payments | -17.57 Million | -3.58 Million | -10.76 Million | -14.22 Million | -16.7 Million | -18.71 Million |
| Common Stock Repurchased | - | - | -70.69 Million | -9.63 Million | -9.48 Million | -8.8 Million |
| Common Stock Issuance | - | - | 70.69 Million | 9.63 Million | 9.48 Million | - |
| Other Financing Activities | 286.42 Million | 460.5 Million | 33.08 Million | 887.47 Million | 264.74 Million | 97.33 Million |
| Accounts receivables | -303.28 Million | -8.24 Million | -48.46 Million | -7.67 Million | -68.15 Million | -30.56 Million |
| Accounts payables | 180.36 Million | -12.74 Million | 9.62 Million | 30.21 Million | -4.46 Million | 15.97 Million |
| Inventory | -51.57 Million | 3.95 Million | -3.59 Million | -6.1 Million | 5.97 Million | -17.91 Million |
| Other working capital | 9.5 Million | -6.29 Million | -3.07 Million | -2.7 Million | -1.46 Million | -14.09 Million |
| Cash at beginning of period | 881.95 Million | 318.71 Million | 904.16 Million | 146.76 Million | 166.94 Million | 78.95 Million |
| Cash at end of period | 412.92 Million | 881.95 Million | 318.71 Million | 904.16 Million | 146.76 Million | 166.94 Million |
| Capital Expenditure | -599.83 Million | -24.57 Million | -40.98 Million | -8.87 Million | -12.89 Million | -16.62 Million |
| Effect of forex changes on cash | -8554.66 | - | 0.25 | 1.07 | - | -11.01 Thousand |
| Net cash flow / Change in cash | -469.03 Million | 563.24 Million | -585.45 Million | 757.39 Million | -20.17 Million | 87.98 Million |
| Free Cash Flow | -916.48 Million | 25.93 Million | -4.95 Million | 91.6 Million | 9.14 Million | 32.04 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -90.88 Million | -86.22 Million | 9.89 Million | -265.24 Million | -177.35 Million | -34.27 Million |
| Depreciation & Amortization | - | 25.93 Million | 25.93 Million | 33.71 Million | 33.71 Million | -8.1 Million |
| Deferred income taxes | - | - | - | -3.82 Million | - | -473.96 Million |
| Stock-based compensation | - | 2.99 Million | - | 8.97 Million | 8.97 Million | -2.99 Million |
| Change in working capital | - | 82.73 Million | - | -178.32 Million | -345.35 Million | 485.05 Million |
| Other non-cash items | 166.46 Million | 42.66 Million | -59.66 Million | 53.55 Million | 487.93 Million | -162.44 Million |
| Investing Cash Flow | -63.16 Million | 191.88 Million | -202.9 Million | -862.53 Million | 138.72 Million | -181.23 Million |
| Investments in PPE | -55.46 Million | -102.07 Million | -54.19 Million | -599.83 Million | -20.72 Million | -28.41 Million |
| Acquisitions | 300.00 | 80.00 | - | -2.85 Million | 419.70 | 948.48 |
| Investment purchases | -18 Million | -55 Million | -244 Million | -1.87 Billion | -494.77 Million | -388.22 Million |
| Sales/Maturities of investments | 10 Million | 349 Million | 110.28 Million | 1.61 Billion | 653.72 Million | 235.39 Million |
| Other Investing Activities | 300 Thousand | -40 Thousand | -15 Million | -259.83 Million | 159.44 Million | 0.83 |
| Financing Cash Flow | -104.68 Million | -156.55 Million | 110.32 Million | 710.15 Million | -10.68 Million | 91.53 Million |
| Debt repayment | -73.92 Million | -141.37 Million | -136.48 Million | -441.3 Million | -283.34 Million | -448.16 Million |
| Dividends payments | - | -13.67 Million | -6.44 Million | -17.57 Million | -3.04 Million | -7.14 Million |
| Common Stock Repurchased | 18.07 Million | -18.07 Million | - | - | - | 12.94 Million |
| Common Stock Issuance | -91.38 Thousand | 91.38 Thousand | - | - | - | -12.94 Million |
| Other Financing Activities | -48.74 Million | 5.92 Million | -19.71 Million | 286.42 Million | 277.42 Million | 546.84 Million |
| Accounts receivables | - | 64.28 Million | - | -303.28 Million | -303.28 Million | 438.75 Million |
| Accounts payables | - | - | - | 180.36 Million | - | 3.74 Million |
| Inventory | - | 18.58 Million | - | -51.57 Million | -51.57 Million | 46.3 Million |
| Other working capital | - | -134.23 Thousand | - | 9.5 Million | 9.5 Million | -3.74 Million |
| Cash at beginning of period | 298.06 Million | 319.19 Million | 412.92 Million | 881.95 Million | 285.95 Million | 574.77 Million |
| Cash at end of period | 186.78 Million | 298.06 Million | 270.57 Million | 412.92 Million | 412.92 Million | 285.95 Million |
| Capital Expenditure | -55.46 Million | -102.07 Million | -54.19 Million | -599.83 Million | -20.72 Million | -28.41 Million |
| Effect of forex changes on cash | - | - | - | -8554.66 | -8554.00 | -2.39 Million |
| Net cash flow / Change in cash | -111.27 Million | -21.13 Million | -142.35 Million | -469.03 Million | 126.97 Million | -288.82 Million |
| Free Cash Flow | 20.11 Million | -171.58 Million | -103.97 Million | -916.48 Million | -21.78 Million | -225.13 Million |
ECLERX
ELIN
8037
6853
6026
VNT